G. E. Torres, R. R. Gainetdinov, and M. G. Caron, Plasma membrane monoamine transporters: structure, regulation and function, Nat Rev Neurosci, vol.4, pp.13-25, 2003.

L. Iversen, Neurotransmitter transporters and their impact on the development of psychopharmacology, Br J Pharmacol, vol.147, issue.1, pp.82-88, 2006.

D. S. Charney, Monoamine dysfunction and the pathophysiology and treatment of depression, J Clin Psychiatry, vol.59, pp.11-14, 1998.

H. K. Manji, W. C. Drevets, and D. S. Charney, The cellular neurobiology of depression, Nat Med, vol.7, pp.541-547, 2001.

H. K. Wayment, J. O. Schenk, and B. A. Sorg, Characterization of extracellular dopamine clearance in the medial prefrontal cortex: role of monoamine uptake and monoamine oxidase inhibition, J Neurosci, vol.21, pp.35-44, 2001.

E. S. Vizi, G. Zsilla, M. G. Caron, and J. P. Kiss, Uptake and release of norepinephrine by serotonergic terminals in norepinephrine transporter knock-out mice: implications for the action of selective serotonin reuptake inhibitors, J Neurosci, vol.24, pp.7888-7894, 2004.

L. C. Daws, S. Montanez, W. A. Owens, G. G. Gould, A. Frazer et al., Transport mechanisms governing serotonin clearance in vivo revealed by high-speed chronoamperometry, J Neurosci Methods, vol.143, pp.49-62, 2005.

D. Grundemann, B. Schechinger, G. A. Rappold, and E. Schomig, Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter, Nat Neurosci, vol.1, pp.349-351, 1998.

V. Vialou, A. Amphoux, R. Zwart, B. Giros, and S. Gautron, Organic cation transporter 3 (Slc22a3) is implicated in salt-intake regulation, J Neurosci, vol.24, pp.2846-2851, 2004.
URL : https://hal.archives-ouvertes.fr/inserm-02008093

A. Amphoux, V. Vialou, E. Drescher, M. Bruss, M. La-cour et al., Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain, Neuropharmacology, vol.50, pp.941-952, 2006.

K. Engel, M. Zhou, and J. Wang, Identification and characterization of a novel monoamine transporter in the human brain, J Biol Chem, vol.279, pp.50042-50049, 2004.

R. Zwart, S. Verhaagh, M. Buitelaar, C. Popp-snijders, and D. P. Barlow, Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3/Slc22a3-deficient mice, Mol Cell Biol, vol.21, pp.4188-4196, 2001.

J. W. Jonker, E. Wagenaar, S. Van-eijl, and A. H. Schinkel, Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations, Mol Cell Biol, vol.23, pp.7902-7908, 2003.

V. Vialou, L. Balasse, J. Callebert, J. M. Launay, B. Giros et al., Altered aminergic neurotransmission in the brain of organic cation transporter 3-deficient mice, J Neurochem, vol.106, pp.1471-1482, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-02008107

N. L. Baganz, R. E. Horton, A. S. Calderon, W. A. Owens, J. L. Munn et al., Organic cation transporter 3: keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice, Proc Natl Acad Sci, vol.105, pp.18976-18981, 2008.

M. Cui, R. Aras, W. V. Christian, P. M. Rappold, M. Hatwar et al., The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway, Proc Natl Acad Sci, vol.106, pp.8043-8048, 2009.

A. E. Busch, U. Karbach, D. Miska, V. Gorboulev, A. Akhoundova et al., Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine, Mol Pharmacol, vol.54, pp.342-352, 1998.

H. Russ, W. Engel, and E. Schomig, Isocyanines and pseudoisocyanines as a novel class of potent noradrenaline transport inhibitors: synthesis, detection, and biological activity, J Med Chem, vol.36, pp.4208-4213, 1993.

V. Fabre, B. Boutrel, N. Hanoun, L. Lanfumey, C. M. Fattaccini et al., Homeostatic regulation of serotonergic function by the serotonin transporter as revealed by nonviral gene transfer, J Neurosci, vol.20, pp.5065-5075, 2000.

E. R. Kandel, W. A. Spencer, B. Jr, and F. J. , Electrophysiology of hippocampal neurons. I. Sequential invasion and synaptic organization, J Neurophysiol, vol.24, pp.225-242, 1961.

D. J. David, M. Bourin, G. Jego, C. Przybylski, P. Jolliet et al., Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice, Br J Pharmacol, vol.140, pp.1128-1136, 2003.

G. A. Ordway, C. A. Stockmeier, G. W. Cason, and V. Klimek, Pharmacology and distribution of norepinephrine transporters in the human locus coeruleus and raphe nuclei, J Neurosci, vol.17, pp.1710-1719, 1997.

L. Marec, N. Hebert, C. Amdiss, F. Botez, M. I. Reader et al., Regional distribution of 5-HT transporters in the brain of wild type and 'Purkinje cell degeneration' mutant mice: a quantitative autoradiographic study with [ 3 H]citalopram, J Chem Neuroanat, vol.15, pp.155-171, 1998.

V. Fabre, C. Beaufour, A. Evrard, A. Rioux, N. Hanoun et al., Altered expression and functions of serotonin 5-HT1A and 5HT1B receptors in knock-out mice lacking the 5-HT transporter, Eur J Neurosci, vol.12, pp.2299-2310, 2000.

D. J. David, K. C. Klemenhagen, K. A. Holick, M. D. Saxe, I. Mendez et al., Efficacy of the MCHR1 antagonist N-[3-(1-{[4(3,4-difluorophenoxy)phenyl]methyl}(4-piperidyl))-4-methylphen yl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis, J Pharmacol Exp Ther, vol.321, pp.237-248, 2007.

R. D. Porsolt, L. Pichon, M. Jalfre, and M. , Depression: a new animal model sensitive to antidepressant treatments, Nature, vol.266, pp.730-732, 1977.

D. J. David, B. A. Samuels, R. Q. Wang, J. W. Marsteller, D. Mendez et al., Neurogenesis-dependent and-independent effects of fluoxetine in an animal model of anxiety/depression, Neuron, vol.62, pp.479-493, 2009.

J. E. Ledoux, Emotion circuits in the brain, Annu Rev Neurosci, vol.23, pp.155-184, 2000.

W. C. Drevets, Prefrontal cortical-amygdalar metabolism in major depression, Ann NY Acad Sci, vol.877, pp.614-637, 1999.

W. C. Drevets, Neuroimaging studies of mood disorders, Biol Psychiatry, vol.48, pp.813-829, 2000.

D. Grundemann, S. Koster, N. Kiefer, T. Breidert, M. Engelhardt et al., Transport of monoamine transmitters by the organic cation transporter type 2, OCT2, J Biol Chem, vol.273, pp.30915-30920, 1998.

G. Gobbi, D. L. Murphy, K. Lesch, and P. Blier, Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study, J Pharmacol Exp Ther, vol.296, pp.987-995, 2001.

S. L. Gourley, F. J. Wu, D. D. Kiraly, J. E. Ploski, A. T. Kedves et al., Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression, Biol Psychiatry, vol.63, pp.353-359, 2008.

M. A. Bunin and R. M. Wightman, Quantitative evaluation of 5-hydroxytryptamine (serotonin) neuronal release and uptake: an investigation of extrasynaptic transmission, J Neurosci, vol.18, pp.4854-4860, 1998.

M. L. Mundorf, J. D. Joseph, C. M. Austin, M. G. Caron, and R. M. Wightman, Catecholamine release and uptake in the mouse prefrontal cortex, J Neurochem, vol.79, pp.130-142, 2001.

K. Mitchell, A. F. Oke, and R. N. Adams, In vivo dynamics of norepinephrine release-reuptake in multiple terminal field regions of rat brain, J Neurochem, vol.63, pp.917-926, 1994.

D. Bengel, D. L. Murphy, A. M. Andrews, C. H. Wichems, D. Feltner et al., Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ('Ecstasy') in serotonin transporter-deficient mice, Mol Pharmacol, vol.53, pp.649-655, 1998.

F. Xu, R. R. Gainetdinov, W. C. Wetsel, S. R. Jones, L. M. Bohn et al., Mice lacking the norepinephrine transporter are supersensitive to psychostimulants, Nat Neurosci, vol.3, pp.465-471, 2000.

Y. I. Sheline, Neuroimaging studies of mood disorder effects on the brain, Biol Psychiatry, vol.54, pp.338-352, 2003.

G. Rajkowska, Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells, Biol Psychiatry, vol.48, pp.766-777, 2000.

H. S. Mayberg, A. M. Lozano, V. Voon, H. E. Mcneely, D. Seminowicz et al., Deep brain stimulation for treatment-resistant depression, Neuron, vol.45, pp.651-660, 2005.

P. Tremblay and P. Blier, Catecholaminergic strategies for the treatment of major depression, Curr Drug Targets, vol.7, pp.149-158, 2006.

C. J. Lin, Y. Tai, M. T. Huang, Y. F. Tsai, H. J. Hsu et al., Cellular localization of the organic cation transporters, OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP transport across the blood-brain barrier and MPTP-induced dopaminergic toxicity in rodents, J Neurochem, vol.114, pp.717-727, 2010.

M. Roche, K. G. Commons, A. Peoples, and R. J. Valentino, Circuitry underlying regulation of the serotonergic system by swim stress, J Neurosci, vol.23, pp.970-977, 2003.

L. K. Heisler, N. Pronchuk, K. Nonogaki, L. Zhou, J. Raber et al., Serotonin activates the hypothalamic-pituitary-adrenal axis via serotonin 2C receptor stimulation, J Neurosci, vol.27, pp.6956-6964, 2007.

J. J. Radley, B. Williams, and P. E. Sawchenko, Noradrenergic innervation of the dorsal medial prefrontal cortex modulates hypothalamopituitary-adrenal responses to acute emotional stress, J Neurosci, vol.28, pp.5806-5816, 2008.

Y. M. Ulrich-lai and J. P. Herman, Neural regulation of endocrine and autonomic stress responses, Nat Rev Neurosci, vol.10, pp.397-409, 2009.

A. C. Linthorst, R. G. Penalva, C. Flachskamm, F. Holsboer, and J. M. Reul, Forced swim stress activates rat hippocampal serotonergic neurotransmission involving a corticotropin-releasing hormone receptor-dependent mechanism, Eur J Neurosci, vol.16, pp.2441-2452, 2002.

S. Ma and D. A. Morilak, Norepinephrine release in medial amygdala facilitates activation of the hypothalamic-pituitary-adrenal axis in response to acute immobilisation stress, J Neuroendocrinol, vol.17, pp.22-28, 2005.

T. Yoshitake, F. H. Wang, E. Kuteeva, K. Holmberg, M. Yamaguchi et al., Enhanced hippocampal noradrenaline and serotonin release in galanin-overexpressing mice after repeated forced swimming test, Proc Natl Acad Sci, vol.101, pp.354-359, 2004.

R. Schreiber, M. Brocco, A. Gobert, S. Veiga, and M. J. Millan, The potent activity of the 5-HT1A receptor agonists, S 14506 and S 14671, in the rat forced swim test is blocked by novel 5-HT1A receptor antagonists, Eur J Pharmacol, vol.271, pp.537-541, 1994.

D. Vry, J. Schreiber, R. Melon, C. Dalmus, M. Jentzsch et al., 5-HT1A receptors are differentially involved in the anxiolytic-and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat, Eur Neuropsychopharmacol, vol.14, pp.487-495, 2004.

S. E. File, L. E. Gonzalez, and N. Andrews, Comparative study of pre-and postsynaptic 5-HT1A receptor modulation of anxiety in two ethological animal tests, J Neurosci, vol.16, pp.4810-4815, 1996.

J. Savitz, I. Lucki, and W. C. Drevets, 5-HT(1A) receptor function in major depressive disorder, Prog Neurobiol, vol.88, pp.17-31, 2009.

Q. Li, C. Wichems, A. Heils, K. P. Lesch, and D. L. Murphy, Reduction in the density and expression, but not G-protein coupling, of serotonin receptors (5-HT1A) in 5-HT transporter knock-out mice: gender and brain region differences, J Neurosci, vol.20, pp.7888-7895, 2000.

H. Koepsell, K. Lips, and C. Volk, Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications, Pharm Res, vol.24, pp.1227-1251, 2007.

P. Blier, G. Pineyro, M. El-mansari, R. Bergeron, and C. De-montigny, Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission, Ann NY Acad Sci, vol.861, pp.204-216, 1998.

T. I. Cremers, P. De-boer, Y. Liao, F. J. Bosker, J. A. Boer et al., Augmentation with a 5-HT(1A), but not a 5-HT(1B) receptor antagonist critically depends on the dose of citalopram, Eur J Pharmacol, vol.397, pp.63-74, 2000.

M. J. Detke, S. Wieland, and I. Lucki, Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5HT1A receptor antagonists, Psychopharmacology (Berl), vol.119, pp.47-54, 1995.

A. Surget, M. Saxe, S. Leman, Y. Ibarguen-vargas, S. Chalon et al., Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal, Biol Psychiatry, vol.64, pp.293-301, 2008.

K. Kobayashi, Y. Ikeda, A. Sakai, N. Yamasaki, E. Haneda et al., Reversal of hippocampal neuronal maturation by serotonergic antidepressants, Proc Natl Acad Sci, vol.107, pp.8434-8439, 2010.

S. U. Yanpallewar, K. Fernandes, S. V. Marathe, K. C. Vadodaria, D. Jhaveri et al., Alpha2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment, J Neurosci, vol.30, pp.1096-1109, 2010.

J. W. Richardson-jones, C. P. Craige, B. P. Guiard, A. Stephen, K. L. Metzger et al., 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants, Neuron, vol.65, pp.40-52, 2010.

J. Beique, C. De-montigny, P. Blier, and G. Debonnel, Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat, Neuropharmacology, vol.39, pp.1800-1812, 2000.

S. T. Szabo and P. Blier, Effects of the selective norepinephrine reuptake inhibitor reboxetine on norepinephrine and serotonin transmission in the rat hippocampus, Neuropsychopharmacology, vol.25, pp.845-857, 2001.

E. Berrocoso and J. A. Mico, In vivo effect of venlafaxine on locus coeruleus neurons: role of opioid, alpha(2)-adrenergic, and 5hydroxytryptamine(1A) receptors, J Pharmacol Exp Ther, vol.322, pp.101-107, 2007.